Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose tranexamic acid after total knee arthroplasty in rheumatoid arthritis
ChiCTR1900025013Phase 4Recruiting
- Sponsor
- Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in rheumatoid arthritis (RA) (2 arms), sponsored by Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Primary endpoints: Hemoglobin, Blood loss and 1 more. Started Aug 2019; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR1900025013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025013.